Dysbiosis and Its Discontents

Katarzyna B Hooks, Maureen A O'Malley, Katarzyna B Hooks, Maureen A O'Malley

Abstract

Dysbiosis is a key term in human microbiome research, especially when microbiome patterns are associated with disease states. Although some questions have been raised about how this term is applied, its use continues undiminished in the literature. We investigate the ways in which microbiome researchers discuss dysbiosis and then assess the impact of different concepts of dysbiosis on microbiome research. After an overview of the term's historical roots, we conduct quantitative and qualitative analyses of a large selection of contemporary dysbiosis statements. We categorize both short definitions and longer conceptual statements about dysbiosis. Further analysis allows us to identify the problematic implications of how dysbiosis is used, particularly with regard to causal hypotheses and normal-abnormal distinctions. We suggest that researchers should reflect carefully on the ways in which they discuss dysbiosis, in order for the field to continue to develop greater predictive scope and explanatory depth.

Keywords: dysbiosis; homeostasis; microbial diversity; microbiome; microbiota.

Copyright © 2017 Hooks and O’Malley.

Figures

FIG 1
FIG 1
The contributions of Metchnikoff, Furney, and Scheunert to dysbiosis thinking. Metchnikoff photo from Les Prix Nobels 1908; Furney book cover from https://babel.hathitrust.org/cgi/pt?id=nnc1.1000947504;view=1up;seq=5; and Scheunert photo from http://www.ullmann-bernau.de/Ahnengemeinschaften (used with permission of the creator of the digital rendition, Steffen Ullmann [original photographer unknown]).
FIG 2
FIG 2
Helmut Haenel’s representations of dysbiosis and eubiosis. Image of Haenel used with permission of the Berlin-Brandenburgische Akademie der Wissenschaften. Figures of eubiosis and dysbiosis reconstructed from the work of Haenel (Fig. 4 and 5 in reference 16).
FIG 3
FIG 3
Definitions of dysbiosis. (A) Types of definitions with sample quotes, sometimes slightly paraphrased. References: , Maynard et al. (2012); , Arrieta et al. (2016); , Nibali et al. (2014); , Williams and Gallo (2015); , Lewis et al. (2015); , Youmans et al. (2015); , Lawley et al. (2012); , Jones et al. (2014); , Bested et al. (2013); , Sommer and Bäckhed (2013). (B) Popularity of different definitions.

References

    1. Olesen SW, Alm EJ. 2016. Dysbiosis is not an answer. Nat Microbiol 1:16228. doi:10.1038/nmicrobiol.2016.228.
    1. Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. 2017. Dysbiosis and the immune system. Nat Rev Immunol 17:219–232. doi:10.1038/nri.2017.7.
    1. Stecher B, Maier L, Hardt WD. 2013. ‘Blooming’ in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol 11:277–284. doi:10.1038/nrmicro2989.
    1. Wing MR, Patel SS, Ramezani A, Raj DS. 2016. Gut microbiome in chronic kidney disease. Exp Physiol 101:471–477. doi:10.1113/EP085283.
    1. Metchnikoff É. 1908. Études sur la flore intestinale. Putréfaction intestinale. Ann Inst Pasteur 22:930–955.
    1. Metchnikoff É. 1903. The nature of man: studies in optimistic philosophy. G. P. Putnam, New York, NY.
    1. Metchnikoff É. 1908. The prolongation of life: optimistic studies. Putnam and Sons, New York, NY.
    1. Furney E. 1891. Culture, a modern method. I. H. Brown & Company, New York, NY.
    1. Scheunert CA. 1920. Über Knochenweiche bei Pferden und ‘Dysbiose der Darmflora.’ Z Infekt 21:105–121.
    1. Joost HG. 2012. Carl Arthur Scheunert’s experiments on human nutrition, 1938-1943: boundary transgressions of a scientist under national socialism. Medizinhist J 47:296–334.
    1. Savage DC. 2001. Microbial biota of the human intestine: a tribute to some pioneering scientists. Curr Issues Intest Microbiol 2:1–15.
    1. Haenel H. 1961. Some rules in the ecology of the intestinal microflora of man. J Appl Bacteriol 24:242–251. doi:10.1111/j.1365-2672.1961.tb00260.x.
    1. Blasiu AP, Diepold G, Ries J. 1954. Therapeutische Mitteilungen: zur Anwendung mikrobieller Stoffwechsel-produkte während und nach der Strahlenbehandlung Krebskranker. Münch Med Wochenschr 96:347–349.
    1. Florkiewicz H, Szurska G. 1963. Rola preparatu Hylak forte* w zapobieganiu dysbakteriozie po doustnym stosowaniu antybiotyków. Pol Tyg Lek 18:1066–1068.
    1. Haenel H, Schmidt EF, Feldheim G. 1959. Fäkale Dysbiose im Säuglingsalter. Z Kinderheilkd 603:595–603.
    1. Haenel H. 1970. Human normal and abnormal gastrointestinal flora. Am J Clin Nutr 23:1433–1439.
    1. Haenel H. 1986, Symposium status and perspectives in gastro-intestinal microecology. Food/Nahrung 30:575–583. doi:10.1002/food.19860300602.
    1. Haenel H, Bendig J. 1975. Intestinal flora in health and disease. Prog Food Nutr Sci 1:21–64.
    1. Prescott SL. 2017. History of medicine: origin of the term microbiome and why it matters. Hum Microbiome J 4:24–25. doi:10.1016/j.humic.2017.05.004.
    1. Petersen C, Round JL. 2014. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol 16:1024–1033. doi:10.1111/cmi.12308.
    1. Vangay P, Ward T, Gerber JS, Knights D. 2015. Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe 17:553–564. doi:10.1016/j.chom.2015.04.006.
    1. Knights D, Lassen KG, Xavier RJ. 2013. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut 62:1505–1510. doi:10.1136/gutjnl-2012-303954.
    1. Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in’t Veld JH. 1998. Overview of gut flora and probiotics. Int J Food Microbiol 41:85–101. doi:10.1016/S0168-1605(98)00044-0.
    1. Antharam VC, Li EC, Ishmael A, Sharma A, Mai V, Rand KH, Wang GP. 2013. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol 51:2884–2892. doi:10.1128/JCM.00845-13.
    1. Chow J, Mazmanian SK. 2010. A pathobiont of the microbiota balances host colonization and intestinal inflammation. Cell Host Microbe 7:265–276. doi:10.1016/j.chom.2010.03.004.
    1. McDonald D, Ackermann G, Khailova L, Baird C, Heyland D, Kozar R, Lemieux M, Derenski K, King J, Vis-Kampen C, Knight R, Wischmeyer PE. 2016. Extreme dysbiosis of the microbiome in critical illness. mSphere 1:e00199-16. doi:10.1128/mSphere.00199-16.
    1. Voigt AY, Costea PI, Kultima JR, Li SS, Zeller G, Sunagawa S, Bork P. 2015. Temporal and technical variability of human gut metagenomes. Genome Biol 16:73. doi:10.1186/s13059-015-0639-8.
    1. Bäckhed F, Fraser CM, Ringel Y, Sanders ME, Sartor RB, Sherman PM, Versalovic J, Young V, Finlay BB. 2012. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 12:611–622. doi:10.1016/j.chom.2012.10.012.
    1. Kim BS, Jeon YS, Chun J. 2013. Current status and future promise of the human microbiome. Pediatr Gastroenterol Hepatol Nutr 16:71–79. doi:10.5223/pghn.2013.16.2.71.
    1. Hooper LV, Littman DR, Macpherson AJ. 2012. Interactions between the microbiota and the immune system. Science 336:1268–1273. doi:10.1126/science.1223490.
    1. Moya A, Ferrer M. 2016. Functional redundancy-induced stability of gut microbiota subjected to disturbance. Trends Microbiol 24:402–413. doi:10.1016/j.tim.2016.02.002.
    1. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. 2012. Diversity, stability and resilience of the human gut microbiota. Nature 489:220–230. doi:10.1038/nature11550.
    1. Chassard C, Dapoigny M, Scott KP, Crouzet L, Del’homme C, Marquet P, Martin JC, Pickering G, Ardid D, Eschalier A, Dubray C, Flint HJ, Bernalier-Donadille A. 2012. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther 35:828–838. doi:10.1111/j.1365-2036.2012.05007.x.
    1. Reid G, Younes JA, Van der Mei HC, Gloor GB, Knight R, Busscher HJ. 2011. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol 9:27–38. doi:10.1038/nrmicro2473.
    1. Eberl G. 2010. A new vision of immunity: homeostasis of the superorganism. Mucosal Immunol 3:450–460. doi:10.1038/mi.2010.20.
    1. Neish AS. 2009. Microbes in gastrointestinal health and disease. Gastroenterology 136:65–80. doi:10.1053/j.gastro.2008.10.080.
    1. Relman DA. 2015. The human microbiome and the future practice of medicine. JAMA 314:1127–1128. doi:10.1001/jama.2015.10700.
    1. Mondot S, de Wouters T, Doré J, Lepage P. 2013. The human gut microbiome and its dysfunctions. Dig Dis 31:278–285. doi:10.1159/000354678.
    1. Iebba V, Totino V, Gagliardi A, Santangelo F, Cacciotti F, Trancassini M, Mancini C, Cicerone C, Corazziari E, Pantanella F, Schippa S. 2016. Eubiosis and dysbiosis: the two sides of the microbiota. New Microbiol 39:1–12.
    1. Shin NR, Whon TW, Bae JW. 2015. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol 33:496–503. doi:10.1016/j.tibtech.2015.06.011.
    1. Jeffery IB, Lynch DB, O’Toole PW. 2016. Composition and temporal stability of the gut microbiota in older persons. ISME J 10:170–182. doi:10.1038/ismej.2015.88.
    1. Shade A. 2017. Diversity is the question, not the answer. ISME J 11:1–6. doi:10.1038/ismej.2016.118.
    1. Johnson KVA, Burnet PWJ. 2016. Microbiome: should we diversify from diversity? Gut Microbes 7:455–458. doi:10.1080/19490976.2016.1241933.
    1. Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, Littmann E, van den Brink MRM, Jenq RR, Taur Y, Sander C, Cross JR, Toussaint NC, Xavier JB, Pamer EG. 2015. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517:205–208. doi:10.1038/nature13828.
    1. Stein RR, Bucci V, Toussaint NC, Buffie CG, Rätsch G, Pamer EG, Sander C, Xavier JB. 2013. Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiota. PLoS Comput Biol 9:e1003388. doi:10.1371/journal.pcbi.1003388.
    1. Rojo D, Méndez-García C, Raczkowska BA, Bargiela R, Moya A, Ferrer M, Barbas C. 2017. Exploring the human microbiome from multiple perspectives: factors altering its composition and function. FEMS Microbiol Rev 41:453–478. doi:10.1093/femsre/fuw046.
    1. Blumstein DT, Levy K, Mayer E, Harte J. 2014. Gastrointestinal dysbiosis. Evol Med Publ Health 2014:163. doi:10.1093/emph/eou029.
    1. Sonnenburg ED, Sonnenburg JL. 2014. Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab 20:779–786. doi:10.1016/j.cmet.2014.07.003.
    1. Oh J, Byrd AL, Park M, NISC Comparative Sequencing Program, Kong HH, Segre JA. 2016. Temporal stability of the human skin microbiome. Cell 165:854–866. doi:10.1016/j.cell.2016.04.008.
    1. Martínez I, Muller CE, Walter J. 2013. Long-term temporal analysis of the human fecal microbiota revealed a stable core of dominant bacterial species. PLoS One 8:e69621. doi:10.1371/journal.pone.0069621.
    1. Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, Clemente JC, Knight R, Heath AC, Leibel RL, Rosenbaum M, Gordon JI. 2013. The long-term stability of the human gut microbiota. Science 341:1237439. doi:10.1126/science.1237439.
    1. Coyte KZ, Schluter J, Foster KR. 2015. The ecology of the microbiome: networks, competition, and stability. Science 350:663–666. doi:10.1126/science.aad2602.
    1. Foster KR, Schluter J, Coyte KZ, Rakoff-Nahoum S. 2017. The evolution of the host microbiome as an ecosystem on a leash. Nature 548:43–51. doi:10.1038/nature23292.
    1. Aldunate M, Srbinovski D, Hearps AC, Latham CF, Ramsland PA, Gugasyan R, Cone RA, Tachedjian G. 2015. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol 6:164. doi:10.3389/fphys.2015.00164.
    1. Lepage P, Leclerc MC, Joossens M, Mondot S, Blottière HM, Raes J, Ehrlich D, Doré J. 2013. A metagenomic insight into our gut’s microbiome. Gut 62:146–158. doi:10.1136/gutjnl-2011-301805.
    1. Casén C, Vebø HC, Sekelja M, Hegge FT, Karlsson MK, Ciemniejewska E, Dzankovic S, Frøyland C, Nestestog R, Engstrand L, Munkholm P, Nielsen OH, Rogler G, Simrén M, Öhman L, Vatn MH, Rudi K. 2015. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment Pharmacol Ther 42:71–83. doi:10.1111/apt.13236.
    1. Schulberg J, De Cruz P. 2016. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease. Intern Med J 46:266–273. doi:10.1111/imj.13003.
    1. Doré J, Corthier G. 2010. The human intestinal microbiota. Gastroenterol Clin Biol 34(Suppl 1):S7–S15. doi:10.1016/S0399-8320(10)70015-4.
    1. Rosebury T. 1962. Microorganisms indigenous to man. McGraw-Hill, New York, NY.
    1. Gevers D, Kugathasan S, Denson LA, Vázquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song SJ, Yassour M, Morgan XC, Kostic AD, Luo C, González A, McDonald D, Haberman Y, Walters T, Baker S, Rosh J, Stephens M, Heyman M, Markowitz J, Baldassano R, Griffiths A, Sylvester F, Mack D, Kim S, Crandall W, Hyams J, Huttenhower C, Knight R, Xavier RJ. 2014. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15:382–392. doi:10.1016/j.chom.2014.02.005.
    1. Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, Kurilshikov A, Bonder MJ, Valles-Colomer M, Vandeputte D, Tito RY, Chaffron S, Rymenans L, Verspecht C, De Sutter L, Lima-Mendez G, D’hoe K, Jonckheere K, Homola D, Garcia R, Tigchelaar EF, Eeckhaudt L, Fu J, Henckaerts L, Zhernakova A, Wijmenga C, Raes J. 2016. Population-level analysis of gut microbiome variation. Science 352:560–564. doi:10.1126/science.aad3503.
    1. Nicolas S, Blasco-Baque V, Fournel A, Gilleron J, Klopp P, Waget A, Ceppo F, Marlin A, Padmanabhan R, Iacovoni JS, Tercé F, Cani PD, Tanti JF, Burcelin R, Knauf C, Cormont M, Serino M. 2017. Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism. Mol Syst Biol 13:921. doi:10.15252/msb.20167356.
    1. Buttó LF, Haller D. 2016. Dysbiosis in intestinal inflammation: cause or consequence. Int J Med Microbiol 306:302–309. doi:10.1016/j.ijmm.2016.02.010.
    1. Wu GD, Lewis JD. 2013. Analysis of the human gut microbiome and association with disease. Clin Gastroenterol Hepatol 11:774–777. doi:10.1016/j.cgh.2013.03.038.
    1. Maynard CL, Elson CO, Hatton RD, Weaver CT. 2012. Reciprocal interactions of the intestinal microbiota and immune system. Nature 489:231–241. doi:10.1038/nature11551.
    1. Arrieta MC, Walter J, Finlay BB. 2016. Human microbiota-associated mice: a model with challenges. Cell Host Microbe 19:575–578. doi:10.1016/j.chom.2016.04.014.
    1. Nibali L, Henderson B, Sadiq ST, Donos N. 2014. Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases. J Oral Microbiol 6. doi:10.3402/jom.v6.22962.
    1. Williams MR, Gallo RL. 2015. The role of the skin microbiome in atopic dermatitis. Curr Allergy Asthma Rep 15:65. doi:10.1007/s11882-015-0567-4.
    1. Lewis JD, Chen EZ, Baldassano RN, Otley AR, Griffiths AM, Lee D, Bittinger K, Bailey A, Friedman ES, Hoffmann C, Albenberg L, Sinha R, Compher C, Gilroy E, Nessel L, Grant A, Chehoud C, Li H, Wu GD, Bushman FD. 2015. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn’s disease. Cell Host Microbe 18:489–500. doi:10.1016/j.chom.2015.09.008.
    1. Youmans BP, Ajami NJ, Jiang ZD, Campbell F, Wadsworth WD, Petrosino JF, DuPont HL, Highlander SK. 2015. Characterization of the human gut microbiome during travelers’ diarrhea. Gut Microbes 6:110–119. doi:10.1080/19490976.2015.1019693.
    1. Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, Deakin LJ, Pickard DJ, Duncan SH, Flint HJ, Clark TG, Parkhill J, Dougan G. 2012. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 8:e1002995. doi:10.1371/journal.ppat.1002995.
    1. Jones ML, Ganopolsky JG, Martoni CJ, Labbé A, Prakash S. 2014. Emerging science of the human microbiome. Gut Microbes 5:446–457. doi:10.4161/gmic.29810.
    1. Bested AC, Logan AC, Selhub EM. 2013. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III—convergence toward clinical trials. Gut Pathog 5:4. doi:10.1186/1757-4749-5-4.
    1. Sommer F, Bäckhed F. 2013. The gut microbiota—masters of host development and physiology. Nat Rev Microbiol 11:227–238. doi:10.1038/nrmicro2974.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren